Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 228-244-5 | CAS number: 6192-13-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study conducted on read-across material
- Justification for type of information:
- Read-across performed with structurally similar substance.
Cross-reference
- Reason / purpose for cross-reference:
- read-across source
Reference
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 8 March 2010 to 25 March 2010
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- Read-across performed with structurally similar substance.
- Reason / purpose for cross-reference:
- other: read-across target
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- histidine for S. typhimurium
tryptophan for E.Coli - Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- rat liver S9
- Test concentrations with justification for top dose:
- 0, 0.15, 0.5, 1.5, 5, 15, 50, 150, 500, 1500 and 5000 µg/plate
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- N-ethyl-N-nitro-N-nitrosoguanidine
- Remarks:
- for WP2uvrA-, TA100 and TA1535 without activation
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- Remarks:
- for TA1537 without activation
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- Remarks:
- for TA98 without activation
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 2-Aminoanthracene
- Remarks:
- for WP2uvrA-, TA100, TA1535 and TA1537 with activation
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- benzo(a)pyrene
- Remarks:
- for TA98 with activation
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)
DURATION
- Preincubation period: 20 min at 37°C
- Exposure duration: 48 h at 37°C
- Expression time (cells in growth medium): na
- Fixation time (start of exposure up to fixation or harvest of cells): na
NUMBER OF CELLS EVALUATED: 1-9.9 x 10^9
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth - Evaluation criteria:
- Dose related increase in revertant frequency over the dose range tested and or a reporducible increase at one or more concentrations in at least one bacterial strain with or without metabolic activiation. Biological relevance of the results will be considered first
- Statistics:
- Statistical significance will not be the only determining factor for a positive response.
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: A fine, particulate precipitate was noted at 5000 µg/plate, this observation did not prevent the scoring of revertant colonies.
RANGE-FINDING/SCREENING STUDIES:
- The test material was non-toxic to the strains of bacteria used (TA100 and WP2uvrA). The test material formulation and S9-mix used in this experiment were both shown to be sterile.
ADDITIONAL INFORMATION ON CYTOTOXICITY:
- The test material caused no visible reduction in the growth of the bacterial background lawn at any dose level and was, therefore, tested up to the maximum recommended dose level of 5000 µg/plate
POSITIVE CONTROL
- All of the positive control chemicals used in the test induced marked increases in the frequency of revertant colonies thus confirming the activity of the S9-mix and the sensitivity of the bacterial strains. - Conclusions:
- The test material was considered to be non-mutagenic under the conditions of this test.
- Executive summary:
The method conforms to the guidelines for bacterial mutagenicity testing published by the major Japanese Regulatory Authorities including METI, MHLW and MAFF. It also meets the requirements of the OECD Guidelines for Testing of Chemicals No. 471: Bacterial Reverse Mutation Test, Method B13/14 of Commission Regulation (EC) Number 440/2008 of 30 May 2008 and the USA, EPA (TSCA) OPPTS harmonised guidelines.
Salmonella typhimurium strains TA1535, TA1537, TA98, TA100 and Escherichia coli strain WP2 uvrA were treated with suspensions of the test material using both the Ames plate incorporation and pre-incubation methods at five dose levels, in triplicate, both with and without the addition of a rat liver homogenate metabolising system (10% liver S9 in standard co-factors). The dose range was determined in a preliminary toxicity assay and was 50 to 5000 µg/plate in the first experiment. The experiment was repeated on a separate day (pre-incubation method) using the same dose range as Experiment 1, fresh cultures of the bacterial strains and fresh test material formulations.
The vehicle (dimethyl sulphoxide) control plates gave counts of revertant colonies within the normal range. All of the positive control chemicals used in the test induced marked increases in the frequency of revertant colonies, both with or without metabolic activation. Thus, the sensitivity of the assay and the efficacy of the S9-mix were validated.
The test material caused no visible reduction in the growth of the bacterial background lawn at any dose level and was, therefore, tested up to the maximum recommended dose level of 5000 µg/plate. A fine, particulate precipitate was noted at 5000 µg/plate, this observation did not prevent the scoring of revertant colonies.
No significant increases in the frequency of revertant colonies were recorded for any of the bacterial strains, with any dose of the test material, either with or without metabolic activation or exposure method.
The test material was considered to be non-mutagenic under the conditions of this test.
Table1: Spontaneous Mutation Rates (Concurrent Negative Controls)
EXPERIMENT 1
Number of revertants (mean number of colonies per plate) |
|||||||||
Base-pair substitution type |
Frameshift type |
||||||||
TA100 |
TA1535 |
WP2uvrA |
TA98 |
TA1537 |
|||||
97 |
|
20 |
|
22 |
|
18 |
|
7 |
|
91 |
(96) |
24 |
(21) |
29 |
(24) |
23 |
(19) |
11 |
(11) |
99 |
|
19 |
|
20 |
|
15 |
|
14 |
|
EXPERIMENT 2
Number of revertants (mean number of colonies per plate) |
|||||||||
Base-pair substitution type |
Frameshift type |
||||||||
TA100 |
TA1535 |
WP2uvrA |
TA98 |
TA1537 |
|||||
114 |
|
21 |
|
25 |
|
15 |
|
14 |
|
105 |
(102) |
24 |
(22) |
13 |
(19) |
12 |
(17) |
12 |
(12) |
86 |
|
20 |
|
19 |
|
25 |
|
11 |
|
Table 2: Test Results: Experiment 1: Without Metabolic Activation
Test Period |
From: 15 March 2010 |
To: 18 March 2010 |
||||||||||
With or without S9-Mix |
Test substance concentration (µg/plate) |
Number of revertants (mean number of colonies per plate) |
||||||||||
Base-pair substitution type |
Frameshift type |
|||||||||||
TA100 |
TA1535 |
WP2uvrA |
TA98 |
TA1537 |
||||||||
- |
0 |
102 82 70 |
(85) 16.2# |
20 13 27 |
(20) 7.0 |
31 24 22 |
(26) 4.7 |
23 18 16 |
(19) 3.6 |
13 9 8 |
(10) 2.6 |
|
- |
50 |
92 89 93 |
(91) 2.1 |
16 14 24 |
(18) 5.3 |
34 16 25 |
(25) 9.0 |
22 15 16 |
(18) 3.8 |
13 12 11 |
(12) 1.0 |
|
- |
150 |
110 74 86 |
(90) 18.3 |
18 27 14 |
(20) 6.7 |
14 22 18 |
(18) 4.0 |
18 19 13 |
(17) 3.2 |
7 11 8 |
(9) 2.1 |
|
- |
500 |
89 82 93 |
(88) 5.6 |
20 16 22 |
(19) 3.1 |
24 19 18 |
(20) 3.2 |
18 16 16 |
(17) 1.2 |
11 9 10 |
(10) 1.0 |
|
- |
1500 |
78 82 82 |
(81) 2.3 |
24 18 21 |
(21) 3.0 |
30 18 15 |
(21) 7.9 |
20 14 18 |
(17) 3.1 |
7 10 9 |
(9) 1.5 |
|
- |
5000 |
118 P 71 P 82 P |
(90) 24.6 |
18 P 22 P 19 P |
(20) 2.1 |
20 P 15 P 22 P |
(19) 3.6 |
18 P 18 P 13 P |
(16) 2.9 |
16 P 8 P 9 P |
(11) 4.4 |
|
Positive controls
S9-Mix
- |
Name Concentration (µg/plate) No. colonies per plate |
ENNG |
ENNG |
ENNG |
4NQO |
9AA |
||||||
3 |
5 |
2 |
0.2 |
80 |
||||||||
586 624 731 |
(647) 75.2 |
154 111 162 |
(142) 27.4 |
242 227 242 |
(237) 8.7 |
102 95 118 |
(105) 11.8 |
1270 1027 935 |
(1077) 173.1 |
ENNGN-ethyl-N'-nitro-N-nitrosoguanidine
4NQO 4-Nitroquinoline-1-oxide
9AA 9-Aminoacridine
P Precipitate
# Standard deviation
Table 3: Test Results: Experiment 1: With Metabolic Activation
Test Period |
From: 15 March 2010 |
To: 18 March 2010 |
||||||||||
With or without S9-Mix |
Test substance concentration (µg/plate) |
Number of revertants (mean number of colonies per plate) |
||||||||||
Base-pair substitution type |
Frameshift type |
|||||||||||
TA100 |
TA1535 |
WP2uvrA¿ |
TA98 |
TA1537 |
||||||||
+ |
0 |
87 75 89 |
(84) 7.6# |
23 16 18 |
(19) 3.6 |
26 31 35 |
(31) 4.5 |
24 30 29 |
(28) 3.2 |
13 9 9 |
(10) 2.3 |
|
+ |
50 |
79 84 77 |
(80) 3.6 |
15 19 13 |
(16) 3.1 |
27 22 27 |
(25) 2.9 |
29 34 20 |
(28) 7.1 |
7 13 8 |
(9) 3.2 |
|
+ |
150 |
87 89 87 |
(88) 1.2 |
18 23 21 |
(21) 2.5 |
22 21 21 |
(21) 0.6 |
27 23 24 |
(25) 2.1 |
13 7 9 |
(10) 3.1 |
|
+ |
500 |
68 66 66 |
(67) 1.2 |
22 16 21 |
(20) 3.2 |
20 23 29 |
(24) 4.6 |
19 21 24 |
(21) 2.5 |
5 13 10 |
(9) 4.0 |
|
+ |
1500 |
82 73 88 |
(81) 7.5 |
12 13 16 |
(14) 2.1 |
21 24 21 |
(22) 1.7 |
21 22 26 |
(23) 2.6 |
11 14 11 |
(12) 1.7 |
|
+ |
5000 |
60 P 74 P 76 P |
(70) 8.7 |
15 P 19 P 19 P |
(18) 2.3 |
26 P 30 P 20 P |
(25) 5.0 |
19 P 21 P 27 P |
(22) 4.2 |
11 P 9 P 12 P |
(11) 1.5 |
|
Positive controls
S9-Mix
+ |
Name Concentration (µg/plate) No. colonies per plate |
2AA |
2AA |
2AA |
BP |
2AA |
||||||
1 |
2 |
10 |
5 |
2 |
||||||||
305 310 280 |
(298) 16.1 |
145 200 156 |
(167) 29.1 |
181 146 184 |
(170) 21.1 |
168 148 119 |
(145) 24.6 |
131 124 155 |
(137) 16.3 |
|||
2AA 2-Aminoanthracene
BP Benzo(a)pyrene
P Precipitate
# Standard deviation
Table 4: Test Results: Experiment 2 ¿ Without Metabolic Activation
Test Period |
From: 22 March 2010 |
To: 25 March 2010 |
||||||||||
With or without S9-Mix |
Test substance concentration (µg/plate) |
Number of revertants (mean number of colonies per plate) |
||||||||||
Base-pair substitution type |
Frameshift type |
|||||||||||
TA100 |
TA1535 |
WP2uvrA |
TA98 |
TA1537 |
||||||||
- |
0 |
106 78 89 |
(91) 14.1# |
22 17 21 |
(20) 2.6 |
21 17 20 |
(19) 2.1 |
15 19 13 |
(16) 3.1 |
11 12 19 |
(14) 4.4 |
|
- |
50 |
106 93 104 |
(101) 7.0 |
11 21 22 |
(18) 6.1 |
24 18 18 |
(20) 3.5 |
17 14 18 |
(16) 2.1 |
10 8 11 |
(10) 1.5 |
|
- |
150 |
100 112 84 |
(99) 14.0 |
31 27 17 |
(25) 7.2 |
17 21 15 |
(18) 3.1 |
14 21 12 |
(16) 4.7 |
8 11 11 |
(10) 1.7 |
|
- |
500 |
97 113 121 |
(110) 12.2 |
24 24 24 |
(24) 0.0 |
20 27 18 |
(22) 4.7 |
12 19 21 |
(17) 4.7 |
9 12 9 |
(10) 1.7 |
|
- |
1500 |
100 72 89 |
(87) 14.1 |
15 25 22 |
(21) 5.1 |
25 21 17 |
(21) 4.0 |
13 14 14 |
(14) 0.6 |
19 13 13 |
(15) 3.5 |
|
- |
5000 |
83 P 92 P 103 P |
(93) 10.0 |
18 P 13 P 22 P |
(18) 4.5 |
19 P 21 P 28 P |
(23) 4.7 |
27 P 12 P 18 P |
(19) 7.5 |
21 P 12 P 19 P |
(17) 4.7 |
|
Positive controls
S9-Mix
- |
Name Concentration (µg/plate) No. colonies per plate |
ENNG |
ENNG |
ENNG |
4NQO |
9AA |
||||||
3 |
5 |
2 |
0.2 |
80 |
||||||||
438 422 470 |
(443) 24.4 |
366 385 443 |
(398) 40.1 |
605 584 623 |
(604) 19.5 |
178 196 184 |
(186) 9.2 |
2484 3236 2411 |
(2710) 456.7 |
|||
ENNG N-ethyl-N'-nitro-N-nitrosoguanidine
4NQO 4-Nitroquinoline-1-oxide
9AA 9-Aminoacridine
P Precipitate
# Standard deviation
Table 5: Test Results: Experiment 2: With Metabolic Activation
Test Period |
From: 22 March 2010 |
To: 25 March 2010 |
||||||||||
With or without S9-Mix |
Test substance concentration (µg/plate) |
Number of revertants (mean number of colonies per plate) |
||||||||||
Base-pair substitution type |
Frameshift type |
|||||||||||
TA100 |
TA1535 |
WP2uvrA¿ |
TA98 |
TA1537 |
||||||||
+ |
0 |
124 100 94 |
(106) 15.9# |
13 13 14 |
(13) 0.6 |
31 21 25 |
(26) 5.0 |
17 21 24 |
(21) 3.5 |
19 14 16 |
(16) 2.5 |
|
+ |
50 |
91 113 89 |
(98) 13.3 |
13 13 13 |
(13) 0.0 |
17 22 21 |
(20) 2.6 |
22 27 22 |
(24) 2.9 |
7 14 12 |
(11) 3.6 |
|
+ |
150 |
80 83 103 |
(89) 12.5 |
24 13 12 |
(16) 6.7 |
25 25 13 |
(21) 6.9 |
14 17 16 |
(16) 1.5 |
11 11 12 |
(11) 0.6 |
|
+ |
500 |
90 96 84 |
(90) 6.0 |
6 11 12 |
(10) 3.2 |
18 28 30 |
(25) 6.4 |
26 19 14 |
(20) 6.0 |
16 11 12 |
(13) 2.6 |
|
+ |
1500 |
86 90 77 |
(84) 6.7 |
13 10 13 |
(12) 1.7 |
21 15 17 |
(18) 3.1 |
19 14 17 |
(17) 2.5 |
14 11 12 |
(12) 1.5 |
|
+ |
5000 |
112 P 112 P 95 P |
(106) 9.8 |
13 P 10 P 10 P |
(11) 1.7 |
32 P 20 P 24 P |
(25) 6.1 |
21 P 18 P 20 P |
(20) 1.5 |
15 P 7 P 20 P |
(14) 6.6 |
|
Positive controls
S9-Mix
+ |
Name Concentration (µg/plate) No. colonies per plate |
2AA |
2AA |
2AA |
BP |
2AA |
||||||
1 |
2 |
10 |
5 |
2 |
||||||||
1399 1269 1343 |
(1337) 65.2 |
249 202 265 |
(239) 32.7 |
297 283 284 |
(288) 7.8 |
379 321 323 |
(341) 32.9 |
319 227 180 |
(242) 70.7 |
2AA 2-Aminoanthracene
BP Benzo(a)pyrene
P Precipitate
# Standard deviation
Data source
Materials and methods
Test material
- Reference substance name:
- dieodymium tricarbonate
- IUPAC Name:
- dieodymium tricarbonate
Constituent 1
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- S. typhimurium, other: TA 98, TA 100, TA 1535 and TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)